Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial-Reference-Cited by-同舟云学术

Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial

Published:2006-11 Issue:5 Volume:152 Page:876-881
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Marmur Jonathan D.,Mitre Cristina A.,Barnathan Elliot,Cavusoglu Erdal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry;Detre;Circulation,1990

2. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: the REPLACE-2 randomized trial;Lincoff;JAMA,2003

3. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel;Kastrati;N Engl J Med,2004

4. Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization;Kandzari;J Am Coll Cardiol,2004

5. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade versus heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: the REPLACE-2 randomized trial;Lincoff;JAMA,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrins: Integrating the Biology and Therapy of Cell–cell Interactions;Clinical Therapeutics;2017-12

2. Effect of a Shortened-Duration Eptifibatide Infusion (75 mg) as Adjunctive Therapy for Percutaneous Coronary Intervention on Inhospital Cardiovascular Outcomes and Bleeding;The American Journal of Cardiology;2015-03

3. Platelet Inhibition by Abciximab Bolus-Only Administration and Oral ADP Receptor Antagonist Loading in Acute Coronary Syndrome Patients: The Blocking and Bridging Strategy;Thrombosis Research;2013-07

4. Abciximab bolus with optional infusion in intervention for ST-elevation myocardial infarction;Scandinavian Cardiovascular Journal;2013-05-22

5. Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions;Drugs;2011-10